However, although HAPLN1 does not lower the CD8: Treg ratio, HAPLN1 may alter the capability of neutrophils and polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) to reach the tumour site [59]. The gene discussed is HAPLN1; the disease is neoplasm.